BioSpace News Archive

Pharm Country

Laxxon Medical to Participate in 25th Annual Needham Growth Conference

Laxxon Medical Corporation announced today their invitation to participate as a private company in the 25th Annual Needham Growth Conference at the Lotte New York Palace Hotel on January 10-12, 2023.

January 5, 2023
·
1 min read
Lone Star Bio

Perspectum Completes $36 Million First Close of Series C Funding Led by Oppenheimer Holdings

Perspectum, a precision health company which develops medical imaging tools to improve the diagnoses of metabolic diseases and cancer, has completed the first close of its Series C funding round.

January 5, 2023
·
3 min read
FDA

Pristine Surgical Receives FDA 510(k) Clearance for Summit™, the World’s First 4K Single-Use Surgical Arthroscope

Pristine Surgical Receives FDA 510(k) Clearance for Summit™, the World’s First 4K Single-Use Surgical Arthroscope.

January 5, 2023
·
3 min read
FDA

Vaxcyte’s VAX-24 Granted FDA Breakthrough Therapy Designation for the Prevention of Invasive Pneumococcal Disease in Adults

Vaxcyte, Inc. announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for VAX-24, the Company’s investigational 24-valent pneumococcal conjugate vaccine (PCV) candidate for the prevention of invasive pneumococcal disease (IPD), in adults.

January 5, 2023
·
10 min read
Biotech Bay

FDA Approves IND Submission Allowing ABVC BioPharma to Proceed With Clinical Study of ABV-1519 for Treatment of Non-Small Cell Lung Cancer

ABVC BioPharma, Inc. today announced that the US Food & Drug Administration notified the company that the IND application for the proposed clinical investigation of BLEX 404, the primary active ingredient in ABV-1519, for advanced inoperable or metastatic EGFR-mutated non-small cell lung cancer.

January 5, 2023
·
3 min read
Business

ChromaDex Named Brianna Gerber Chief Financial Officer

ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company dedicated to healthy aging, announced that it has appointed Brianna Gerber to the role of Chief Financial Officer, effective January 1, 2023.

January 5, 2023
·
4 min read
BioMidwest

INVO Bioscience Enters Distribution Agreement for Taiwan

INVO Bioscience, Inc. announced it has entered an exclusive distribution agreement with Ming Mei Technology Co. Ltd for Taiwan.

January 5, 2023
·
4 min read
Lone Star Bio

FDA Grants Lantern Pharma Orphan Drug Designation for Drug Candidate LP-284 in Mantle Cell Lymphoma

Lantern Pharma Inc. (NASDAQ: LTRN) today announced that the U.S. Food and Drug Administration (FDA) has granted LP-284 Orphan Drug Designation (ODD) for the treatment of mantle cell lymphoma (MCL).

January 5, 2023
·
7 min read
Genetown

Xenetic Biosciences, Inc. to Present at the Virtual Investor 2023 Companies to Watch Event

Xenetic Biosciences, Inc. today announced that Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences will present at the Virtual Investor 2023 Companies to Watch Event on Tuesday, January 17, 2023 at 10:00 AM ET.

January 5, 2023
·
1 min read
Genetown

Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics

Akamis Bio (formerly PsiOxus Therapeutics), a clinical-stage oncology company leveraging its Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to positively impact the lives of people living with cancer, today announced a $30 million convertible note financing co-led by a group of leading US life science investors.

January 5, 2023
·
7 min read